The Scientific Advisory Board (SAB) of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) program met in September to discuss the results of the HIV Prevention Trials Network (HPTN) 052 trial, which found that individuals with HIV infection who were given immediate antiretroviral therapy (ART) were 96 percent less likely to transmit the virus […]
The TB Alliance announced Tuesday that it has enlisted the help of the National Institute of Allergy and Infectious Diseases (NIAID) AIDS Clinical Trial Group (ACTG) to help complete testing of a potentially shorter tuberculosis treatment regimen utilizing an antibiotic not currently registered to treat TB – moxifloxacin.
Dr. Mean Chhi Vun, director of Cambodia’s National Center for HIV/AIDS, Dermatology and STDs (NCHADS), offered an exciting progress report to the TB/HIV Working Group of the Stop TB Partnership at their meeting last week in Beijing, including representatives from tuberculosis (TB) and HIV programs in China and elsewhere in the Pacific region…
HIV
From 2016 to 2017, 14% of people living with HIV in the United States did something to save money on the out-of-pocket costs of their prescription […]
Tuberculosis
Incorporating patient data from national TB programs and from ongoing research, the World Health Organization has updated its guidelines on treatment for drug-resistant tuberculosis with an […]
Research & Development
While the committee examining the Ebola epidemic in the Democratic Republic of Congo emerged today from its 5th meeting with the conclusion that transmissions of the […]
Policy
DRC, Liberia, Madagascar, Somalia and Ukraine account for nearly half of global measles cases Measles incidence increased in five regions around the world between 2016 and […]